vanadium has been researched along with Precancerous Conditions in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chakraborty, P; Chatterjee, M; Datta, S; Hemalatha, P; Kanna, PS; Mahendrakumar, CB | 1 |
| Chatterjee, M; Elayaraja, T; Indira, BN; Kalaiselvi, K; Kanna, PS; Mahendrakumar, CB; Srivastawa, S | 1 |
| Chatterjee, M; Ghosh, S; Kumar, M; Roy, S; Sankar Ray, R | 1 |
| Chakraborty, T; Chatterjee, M; Ghosh, B; Samanta, S; Thirumoorthy, N | 1 |
| Chakraborty, T; Chatterjee, A; Chatterjee, M; Dhachinamoorthi, D; Saralaya, MG | 1 |
| Chakraborty, T; Chatterjee, A; Chatterjee, M; Dhachinamoorthi, D; Panayappan, L; Srivastawa, S | 1 |
| Chakraborty, T; Chatterjee, A; Chatterjee, M; Rana, B; Shyamsundar, A; Swamy, AH | 1 |
| Chatterjee, M; Rajkumar, M; Rana, A; Rana, B; Samanta, S; Suresh, D; Swamy, V | 1 |
| Basak, R; Chatterjee, M; Saha, BK | 1 |
| Basak, R; Chatterjee, M | 1 |
10 other study(ies) available for vanadium and Precancerous Conditions
| Article | Year |
|---|---|
Vanadium inhibits placental glutathione S-transferase (GST-P) positive foci in 1,2-dimethyl hydrazine induced rat colon carcinogenesis.
Topics: 1,2-Dimethylhydrazine; Animals; Antineoplastic Agents; Body Weight; Carcinogens; Colonic Neoplasms; Glutathione Transferase; Immunohistochemistry; Liver; Male; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Vanadium | 2003 |
Chemopreventive effects of vanadium toward 1,2-dimethylhydrazine-induced genotoxicity and preneoplastic lesions in rat colon.
Topics: 1,2-Dimethylhydrazine; Animals; Catalase; Colon; Comet Assay; DNA Damage; Glutathione Reductase; Intestinal Mucosa; Male; Mutagens; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Vanadium | 2004 |
Suppression of cell proliferation, DNA protein cross-links, and induction of apoptosis by vanadium in chemical rat mammary carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Carcinogens; Cell Proliferation; Cross-Linking Reagents; DNA; Electrophoresis, Agar Gel; Female; In Situ Nick-End Labeling; Liver; Mammary Neoplasms, Experimental; Precancerous Conditions; Proteins; Rats; Rats, Sprague-Dawley; Vanadium; Water | 2004 |
Vanadium induces apoptosis and modulates the expressions of metallothionein, Ki-67 nuclear antigen, and p53 during 2-acetylaminofluorene-induced rat liver preneoplasia.
Topics: 2-Acetylaminofluorene; Animals; Apoptosis; Body Weight; DNA Damage; Gene Expression Regulation; Ki-67 Antigen; Liver; Male; Metallothionein; Metals; Organ Size; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Tumor Suppressor Protein p53; Vanadium | 2005 |
Vanadium inhibits the development of 2-acetylaminofluorene-induced premalignant phenotype in a two-stage chemical rat hepatocarcinogenesis model.
Topics: 2-Acetylaminofluorene; Animals; Anticarcinogenic Agents; Body Weight; Carcinogens; Chromosome Aberrations; gamma-Glutamyltransferase; Glutathione Transferase; Hepatectomy; Immunohistochemistry; Liver; Liver Neoplasms, Experimental; Male; Metals; Organ Size; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Spectrophotometry, Atomic; Vanadium | 2006 |
Vanadium limits the expression of proliferating cell nuclear antigen and inhibits early DNA damage during diethylnitrosamine-induced hepatocellular preneoplasia in rats.
Topics: Animals; Anticarcinogenic Agents; Body Weight; Diethylnitrosamine; DNA Damage; gamma-Glutamyltransferase; Glycogen; Liver; Liver Neoplasms; Male; Organ Size; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Vanadium | 2006 |
Molecular basis of vanadium-mediated inhibition of hepatocellular preneoplasia during experimental hepatocarcinogenesis in rats.
Topics: Animals; Anticarcinogenic Agents; Carcinogens; Cell Proliferation; Cell Transformation, Neoplastic; Chemoprevention; Diethylnitrosamine; DNA Damage; Dose-Response Relationship, Drug; Liver Neoplasms, Experimental; Male; Phenobarbital; Precancerous Conditions; Random Allocation; Rats; Rats, Sprague-Dawley; Vanadium | 2007 |
Protective effects of vanadium against DMH-induced genotoxicity and carcinogenesis in rat colon: removal of O(6)-methylguanine DNA adducts, p53 expression, inducible nitric oxide synthase downregulation and apoptotic induction.
Topics: 1,2-Dimethylhydrazine; Animals; Apoptosis; Colon; Colonic Neoplasms; DNA Adducts; Down-Regulation; Fluorescent Antibody Technique; Guanine; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Tumor Suppressor Protein p53; Vanadium | 2008 |
Inhibition of diethylnitrosamine-induced rat liver chromosomal aberrations and DNA-strand breaks by synergistic supplementation of vanadium and 1alpha,25-dihydroxyvitamin D(3).
Topics: Animals; Antineoplastic Agents; Calcitriol; Chromosome Aberrations; Diethylnitrosamine; DNA Damage; Drug Synergism; Liver; Liver Neoplasms, Experimental; Male; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Vanadium | 2000 |
Combined supplementation of vanadium and 1alpha,25-dihydroxyvitamin D3 inhibit placental glutathione S-transferase positive foci in rat liver carcinogenesis.
Topics: Administration, Oral; Animals; Body Weight; Calcitriol; Carcinogens; Diethylnitrosamine; Drug Interactions; Glutathione Transferase; Hepatectomy; Hepatocytes; Liver Neoplasms; Male; Neoplasms, Experimental; Phenobarbital; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Vanadium; Water Supply | 2000 |